Michael Panzara

Biography

 Dr. Panzara has 15 years of biopharmaceutical industry experience developing therapies for neurological disorders. He served most recently as the Head of the Multiple Sclerosis, Neurology and Ophthalmology Therapeutic Area for Global Development at Sanofi Genzyme, where he was responsible for development strategy and oversight for compounds within these therapeutic areas. He joined Genzyme in 2009 as Group Vice President, Multiple Sclerosis and Immune Diseases, overseeing the development of Multiple Sclerosis (MS) and other inflammatory disease therapies, including the worldwide regulatory approvals of two MS drugs, Lemtrada (alemtuzumab) and Aubagio (teriflunomide). Prior to joining Genzyme, Dr. Panzara was Vice President, Chief Medical Officer, Neurology for Biogen. Dr. Panzara received his undergraduate degree from the University of Pennsylvania and medical degree from Stanford University School of Medicine. He trained in neurology at Massachusetts General Hospital, received his post-doctoral training in immunology and rheumatology at Brigham and Women's Hospital, and received his MPH from the Harvard School of Public Health.

Research Interest

 Immunology